4.7 Article

Deep learning-based identification of genetic variants: application to Alzheimer's disease classification

期刊

BRIEFINGS IN BIOINFORMATICS
卷 23, 期 2, 页码 -

出版社

OXFORD UNIV PRESS
DOI: 10.1093/bib/bbac022

关键词

deep learning; genetic variants; Alzheimer's disease; genome-wide association studies; phenotype influence scores

资金

  1. Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]
  2. DOD ADNI (Department of Defense) [W81XWH-12-2-0012]
  3. National Institutes of Health (NIH) [U01 AG024904, P30 AG010133, P30 AG072976, R01 AG019771, R01 AG057739, R01 LM013463, R01 AG068193, T32 AG071444, U01 AG068057, R01 LM012535, R03 AG063250]

向作者/读者索取更多资源

This paper proposes a deep learning-based approach for identification of phenotype-associated SNPs and developing a classification model for AD. The final classification model achieves good accuracy in terms of area under the curve.
Deep learning is a promising tool that uses nonlinear transformations to extract features from high-dimensional data. Deep learning is challenging in genome-wide association studies (GWAS) with high-dimensional genomic data. Here we propose a novel three-step approach (SWAT-CNN) for identification of genetic variants using deep learning to identify phenotype-related single nucleotide polymorphisms (SNPs) that can be applied to develop accurate disease classification models. In the first step, we divided the whole genome into nonoverlapping fragments of an optimal size and then ran convolutional neural network (CNN) on each fragment to select phenotype-associated fragments. In the second step, using a Sliding Window Association Test (SWAT), we ran CNN on the selected fragments to calculate phenotype influence scores (PIS) and identify phenotype-associated SNPs based on PIS. In the third step, we ran CNN on all identified SNPs to develop a classification model. We tested our approach using GWAS data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) including (N = 981; cognitively normal older adults (CN) = 650 and AD = 331). Our approach identified the well-known APOE region as the most significant genetic locus for AD. Our classification model achieved an area under the curve (AUC) of 0.82, which was compatible with traditional machine learning approaches, random forest and XGBoost. SWAT-CNN, a novel deep learning-based genome-wide approach, identified AD-associated SNPs and a classification model for AD and may hold promise for a range of biomedical applications.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

APOE ε2 resilience for Alzheimer's disease is mediated by plasma lipid species: Analysis of three independent cohort studies

Tingting Wang, Kevin Huynh, Corey Giles, Natalie A. Mellett, Thy Duong, Anh Nguyen, Wei Ling Florence Lim, Alex A. T. Smith, Gavriel Olshansky, Gemma Cadby, Joseph Hung, Jennie Hui, John Beilby, Gerald F. Watts, Pratishtha Chatterjee, Ian Martins, Simon M. Laws, Ashley Bush, Christopher C. Rowe, Victor L. Villemagne, David Ames, Colin L. Masters, Kevin Taddei, Vincent Dore, Juergen Fripp, Matthias Arnold, Gabi Kastenmueller, Kwangsik Nho, Andrew J. Saykin, Rebecca Baillie, Xianlin Han, Ralph N. Martins, Eric K. Moses, Rima Kaddurah-Daouk, Peter J. Meikle

Summary: The APOE genotype is strongly associated with late-onset Alzheimer's disease, with specific lipid species mediating up to 30% and 10% of the treatment effect of APOE epsilon 2 and epsilon 4, respectively. Plasma lipid species represent a potential therapeutic target for Alzheimer's disease.

ALZHEIMERS & DEMENTIA (2022)

Article Clinical Neurology

Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum

Duygu Tosun, Zeynep Demir, Dallas P. Veitch, Daniel Weintraub, Paul Aisen, Clifford R. Jack, William J. Jagust, Ronald C. Petersen, Andrew J. Saykin, Leslie M. Shaw, John Q. Trojanowski, Michael W. Weiner

Summary: Aβ, tau, and neurodegeneration have significant impacts on cognitive impairment and cognitive decline, while AD risk factors also play an important role in affecting disease progression.

ALZHEIMERS & DEMENTIA (2022)

Article Clinical Neurology

Integrative metabolomics-genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease

Emrin Horgusluoglu, Ryan Neff, Won-Min Song, Minghui Wang, Qian Wang, Matthias Arnold, Jan Krumsiek, Beatriz Galindo-Prieto, Chen Ming, Kwangsik Nho, Gabi Kastenmueller, Xianlin Han, Rebecca Baillie, Qi Zeng, Shea Andrews, Haoxiang Cheng, Ke Hao, Alison Goate, David A. Bennett, Andrew J. Saykin, Rima Kaddurah-Daouk, Bin Zhang

Summary: This study aims to identify AD-specific metabolomic changes and their potential upstream genetic and transcriptional regulators through an integrative systems biology framework. The findings suggest that short-chain acylcarnitines/amino acids and medium/long-chain acylcarnitines are most associated with AD clinical outcomes. Integration of gene expression data reveals ABCA1 and CPT1A are involved in regulating acylcarnitines and amino acids in AD.

ALZHEIMERS & DEMENTIA (2022)

Article Oncology

Impact of taxane-based chemotherapy among older women with breast cancer on cognition and quality of life: a longitudinal pooled analysis

Brent J. Small, Marie Lange, Wanting Zhai, Jaeil Ahn, Tim A. Ahles, Judith E. Carroll, Harvey J. Cohen, Deena Graham, Martine Extermann, Natacha Heutte, Heather S. L. Jim, Brenna C. McDonald, Sunita K. Patel, James C. Root, Andrew J. Saykin, Kathleen Van Dyk, Xingtao Zhou, Jeanne Mandelblatt, Florence Joly

Summary: Pooled individual-level data from two large prospective studies of older breast cancer survivors showed that older women who received taxane-based chemotherapy did not experience greater declines in cognitive performance or well-being compared to women receiving other chemotherapy regimens. Despite being at greater risk for negative outcomes, treatment with taxane-based chemotherapies did not exacerbate these health consequences for older cancer survivors.

BREAST CANCER RESEARCH AND TREATMENT (2022)

Article Endocrinology & Metabolism

Genome-wide association study of brain arteriolosclerosis

Lincoln M. P. Shade, Yuriko Katsumata, Timothy J. Hohman, Kwangsik Nho, Andrew J. Saykin, Shubhabrata Mukherjee, Kevin L. Boehme, John S. K. Kauwe, Lindsay A. Farrer, Gerard D. Schellenberg, Jonathan L. Haines, Richard P. Mayeux, Julie A. Schneider, Peter T. Nelson, David W. Fardo

Summary: This study identified putative loci associated with the risk of brain arteriolosclerosis (B-ASC) through a genome-wide association study. The findings provide clues for further understanding the genetic mechanism of B-ASC.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2022)

Article Peripheral Vascular Disease

Visit-to-Visit Blood Pressure Variability and Longitudinal Tau Accumulation in Older Adults

Isabel J. Sible, Daniel A. Nation

Summary: This study found that blood pressure variability (BPV) in older adults is related to tau accumulation in brain regions vulnerable to Alzheimer's disease, independent of average blood pressure levels. The relationship is modified by APOE ε4 carrier status. BPV may serve as a marker of vascular dysfunction contributing to early-stage tau pathology in Alzheimer's disease.

HYPERTENSION (2022)

Article Neurosciences

Integrative Co-methylation Network Analysis Identifies Novel DNA Methylation Signatures and Their Target Genes in Alzheimer?s Disease

Jun Pyo Kim, Bo-Hyun Kim, Paula J. Bice, Sang Won Seo, David A. Bennett, Andrew J. Saykin, Kwangsik Nho

Summary: Through analysis of data from two independent cohorts, we found that DNA methylation alterations may be involved in Alzheimer's disease (AD), and identified 15 key CpG sites associated with AD pathology.

BIOLOGICAL PSYCHIATRY (2023)

Review Neuroimaging

Altered cerebral blood flow in older adults with Alzheimer's disease: a systematic review

Cecily G. Swinford, Shannon L. Risacher, Yu-Chien Wu, Liana G. Apostolova, Sujuan Gao, Paula J. Bice, Andrew J. Saykin

Summary: The prevalence of Alzheimer's disease in the U.S. is expected to reach 13 million by 2050. Currently, there are no treatments available to stop or reverse the progressive cognitive decline associated with the disease. Preventive treatment before significant cognitive decline occurs may be the solution, but there is a need for a reliable biomarker to identify older adults at highest risk. Quantitative cerebral blood flow shows promise as a potential early biomarker for Alzheimer's disease, but further research is needed to fully understand the patterns of altered blood flow.

BRAIN IMAGING AND BEHAVIOR (2023)

Letter Clinical Neurology

Aberrant GAP43 Gene Expression Is Alzheimer Disease Pathology-Specific

Jung-Min Pyun, Young Ho Park, Jiebiao Wang, Paula J. Bice, David A. Bennett, SangYun Kim, Andrew J. Saykin, Kwangsik Nho

ANNALS OF NEUROLOGY (2023)

Article Oncology

Genetic Variants Associated with Longitudinal Cognitive Performance in Older Breast Cancer Patients and Controls †

Kelly Nudelman, Kwangsik Nho, Michael Zhang, Brenna C. McDonald, Wanting Zhai, Brent J. Small, Claire E. Wegel, Paul B. Jacobsen, Heather S. L. Jim, Sunita K. Patel, Deena M. A. Graham, Tim A. Ahles, James C. Root, Tatiana Foroud, Elizabeth C. Breen, Judith E. Carroll, Jeanne S. Mandelblatt, Andrew J. Saykin

Summary: This study found that genetics may play an important role in modifying risk for cognitive decline in older female breast cancer survivors. Several genetic variants and genes were identified to be associated with differences in patterns of cognitive decline in cancer patients compared to controls. Further research and validation of these findings in other cancer populations is necessary to inform therapeutic research and evaluations of risk for cognitive decline in older cancer survivors.

CANCERS (2023)

Article Cell Biology

A protein panel in cerebrospinal fluid for diagnostic and predictive assessment of Alzheimer's disease

Rafi Haque, Caroline M. Watson, Jiaqi Liu, E. Kathleen Carter, Duc M. Duong, James J. Lah, Aliza P. Wingo, Blaine R. Roberts, Erik C. B. Johnson, Andrew J. Saykin, Leslie M. Shaw, Nicholas T. Seyfried, Thomas S. Wingo, Allan I. Levey

Summary: This study developed a reliable and high-throughput mass spectrometry assay to detect 48 key proteins in cerebrospinal fluid (CSF), and found that this panel of proteins performed at least as well as existing biomarkers in predicting clinical diagnosis, brain imaging results, cognitive decline, and dementia severity in Alzheimer's disease. Combining this panel with existing biomarkers significantly improved diagnostic accuracy and prediction of disease progression.

SCIENCE TRANSLATIONAL MEDICINE (2023)

Article Genetics & Heredity

Genome-Wide Association Analysis across Endophenotypes in Alzheimer's Disease: Main Effects and Disease Stage-Specific Interactions

Thea J. Rosewood, Kwangsik Nho, Shannon L. Risacher, Sujuan Gao, Li Shen, Tatiana Foroud, Andrew J. Saykin

Summary: The genetic susceptibility for Alzheimer's disease (AD) is not fully understood. This study used an endophenotype approach to identify genetic associations and discovered novel genetic loci related to AD. These findings provide deeper insights into the genetic mechanisms underlying AD.
Article Sport Sciences

Gene Expression Alterations in Peripheral Blood Following Sport-Related Concussion in a Prospective Cohort of Collegiate Athletes: A Concussion Assessment, Research and Education (CARE) Consortium Study

Edward Simpson, Jill L. Reiter, Jie Ren, Zhiqi Zhang, Kelly N. Nudelman, Larry D. Riggen Jr, Michael D. Menser, Jaroslaw Harezlak, Tatiana M. Foroud, Andrew J. Saykin, Alison Brooks, Kenneth L. Cameron, Stefan M. Duma, Gerald Mcginty, Steven Rowson, Steven J. Svoboda, Steven P. Broglio, Michael A. McCrea, Paul F. Pasquina, Thomas W. Mcallister, Yunlong Liu, CARE Consortium Investigators

Summary: This study analyzed the gene expression changes in peripheral blood following concussion in collegiate athletes. The results showed immediate activation of cytokine and immune response signaling pathways, which later seemed to be suppressed. Additionally, the study found an increase in neutrophils and a decrease in natural killer cells in the blood following concussion.

SPORTS MEDICINE (2023)

暂无数据